Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.01
67.66
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Guangzhou Kingmed Diagnostics Group Co Ltd
Additional Paid In Capital
Guangzhou Kingmed Diagnostics Group Co Ltd
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Additional Paid In Capital
ÂĄ1.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
||
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Additional Paid In Capital
ÂĄ3.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Topchoice Medical Co Inc
SSE:600763
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Additional Paid In Capital
ÂĄ9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
36%
|
||
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Additional Paid In Capital
ÂĄ1.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
||
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Additional Paid In Capital
ÂĄ2.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
117%
|
Guangzhou Kingmed Diagnostics Group Co Ltd
Glance View
Guangzhou Kingmed Diagnostics Group Co., Ltd. engages in the provision of outsourced medical examination and pathological diagnosis services to medical institutions. The company is headquartered in Guangzhou, Guangdong and currently employs 12,371 full-time employees. The company went IPO on 2017-09-08. The firm is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
See Also
What is Guangzhou Kingmed Diagnostics Group Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
1.5B
CNY
Based on the financial report for Sep 30, 2024, Guangzhou Kingmed Diagnostics Group Co Ltd's Additional Paid In Capital amounts to 1.5B CNY.
What is Guangzhou Kingmed Diagnostics Group Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
12%
Over the last year, the Additional Paid In Capital growth was -5%. The average annual Additional Paid In Capital growth rates for Guangzhou Kingmed Diagnostics Group Co Ltd have been 8% over the past three years , 12% over the past five years .